Drug Profile
Research programme: nanobubble therapeutics - ImaRx
Alternative Names: MRX-804; MRX-820; MRX-850; NanO2Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator ImaRx Therapeutics
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Stroke
Most Recent Events
- 07 Feb 2006 Preclinical trials in Stroke in USA (unspecified route)